Modular Medical, Inc. (MODD) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

Operator

Good day, and welcome to the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026. Our next presenting company is Modular Medical Inc. [Operator Instructions] I’d now like to turn the floor over to today’s host, Jeb Besser, CEO, Modular Medical, Inc. Please go ahead.

James Besser
Chief Executive Officer

Thank you, and thanks to everyone who’s come to listen to our presentation. We’re Modular Medical, ticker MODD on the NASDAQ, and we’re a now commercial-stage medical device company commercializing a next-generation insulin pump.

Through the forward-looking statement that we all love to read.

And so Modular Medical is a medical device company commercializing next-generation insulin pump, which is designed to give a higher standard of glycemic management to people who have diabetes by offering them benefits of a pump while offering an attractive form factor and a simpler experience than has historically been available.

The company was founded by Paul DiPerna, who founded Tandem Diabetes, ticker TNDM, and who designed their original insulin pump. We were cleared by the FDA with our device that we’re going to market with in April of 2026. We put our first patient on right at the end of June. And we plan to roll out in multiple cities, five actually starting in October of 2026 and then broaden the launch from there. We believe that the pump addresses a $3 billion market. And of course, as you already know, we’re publicly traded.

So the first question that people usually have when they look at the company is, well, why is there an opportunity for a new company to come into the insulin pump space? There are